AI-Pathway Companion Prostate Cancer from Siemens Healthineers Approved for Use in Europe as Medical Device
AI-Pathway Companion Prostate Cancer(2), a digital companion from Siemens Healthineers to support clinical decision-making, has recently received the CE mark for use in the clinical pathway of prostate cancer, the second most common cancer (after lung cancer) affecting males worldwide.(3)
Source: eHealth News EU - Category: Information Technology Tags: Featured Siemens Healthineers Business and Industry Source Type: news
More News: Cancer | Cancer & Oncology | Information Technology | Lung Cancer | Medical Devices | Prostate Cancer